| Filtered Drugs - 2024 PolicyReference |
last updated: 10/06/2025 |
| A |
generic (Brand)AdminPrep |
abatacept (Orencia)Admin: 0.2-1.2 micron
| Filter size: |
0.2-1.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding filter.10 |
|
| Abraxane - see PACLitaxel, protein-bound |
| Adakveo - see crizanlizumab-tmca |
ado-trastuzumab emtansine (Kadcyla)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with an in-line PES filter.11 |
|
agalsidase beta (Fabrazyme)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with an in-line low-protein-binding filter; do not use a filter during preparation.12 |
|
| Aldurazyme - see laronidase |
alglucosidase alfa (Lumizyme)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with an in-line low-protein-binding filter; do not use a filter during preparation.13 |
|
alpha-1 proteinase inhibitor (Aralast)Admin: N/A
| Filter size: |
N/A |
| Administration: |
Filters not required by manufacturer. All brand names have been checked, but only the specified brand name products (Glassia, Prolastin C Liquid, Zemaira) require filtration. The most up-to-date package insert should be periodically reviewed for the most current recommendations. |
|
alpha-1 proteinase inhibitor (Glassia)Admin: 5 micronPrep: 5 micron
| Filter size: |
5 micron (preparation and administration) |
| Preparation: |
Use the sterile filter needle provided by the manufacturer to transfer the solution to the infusion container. |
| Administration: |
Administer with an in-line filter.14 All brand names have been checked, but only the specified brand name product(s) require filtration. The most up-to-date package insert should be periodically reviewed for the most current recommendations. |
|
alpha-1 proteinase inhibitor (Prolastin C Liquid)Admin: 5-15 micron
| Filter size: |
5-15 micron |
| Administration: |
Administer with an infusion filter.15 All brand names have been checked, but only the specified brand name product(s) require filtration. The most up-to-date package insert should be periodically reviewed for the most current recommendations. |
|
alpha-1 proteinase inhibitor (Zemaira)Admin: 5 micronPrep: 15 micron
| Filter size: |
15 micronb (preparation), 5 micron (administration), |
| Preparation: |
Use the filter vial transfer set provided by the manufacturer during preparation.16 |
| Administration: |
Administer with an in-line filter.5,7 All brand names have been checked, but only the specified brand name product(s) require filtration. The most up-to-date package insert should be periodically reviewed for the most current recommendations. |
|
| Alphanate - see antihemophilic factor VIII/Von Willebrand factor complex |
| AmB-D - see amphotericin B deoxycholate |
| AmBisome - see amphotericin B liposomal |
amino acids (Aminosyn II, Aminosyn-PF, Clinimix, Clinimix E, Clinisol, Plenamine, Premasol, ProSol, Synthamin, Travasol, TrophAmine)Admin: 0.22 micron
| Filter size: |
See comments |
| Administration: |
ASPEN and the INS recommend a 1.2 micron filter for both lipid-containing and lipid-free PN solutions.8,9 |
| IMH Comment: |
TPN (non-lipid containing): Use a 0.22 micron inline filter (stocked in storeroom). |
|
amino acids, electrolytes, dextrose, and lipid injectable (Kabiven, Perikabiven)Admin: 1.2 micon
| Filter size: |
1.2 micron |
| Administration: |
Administer with an in-line filter.17,18 An air-eliminating filter is recommended for lipid-containing PN solution.6 |
|
| Aminosyn - see amino acids |
amiodarone (Nexterone)Admin: See comments
| Filter size: |
See comments |
| Administration: |
Administer with an in-line filter.19 The manufacturer does not provide a filter size recommendation. One study suggests no loss of potency with the use of a 0.22 micron cellulose ester membrane filter.5-7 FOOTNOTE: Both the specified branded product and the conventional generic product require filtration.c |
|
amivantamab (Rybrevant)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding, in-line PES filter.20 |
|
| Amondys 45 - see casimersen |
amphotericin B cholesteryl sulfate (Amphotec)Admin: N/A
| Filter size: |
N/A |
| Administration: |
Only the amphotericin B liposomal (AmBisome) product requires the user to provide a filter. |
|
amphotericin B deoxycholate (AmB-D, Amphocin, Fungizone)Admin: 0.1 micron or larger
| Filter size: |
0.1 micron or larger |
| Administration: |
Only the amphotericin B liposomal (AmBisome) product requires the user to provide a filter. An in-line filter (1 micron or larger) may be used during administration of amphotericin B desoxycholate.180-182 |
|
amphotericin B liposomal (AmBisome)Admin: 1 micron or largerPrep: 5 micron
| Filter size: |
5 micron (preparation), 1 micron or larger (administration) |
| Preparation: |
Use the 5 micron filter provided by the manufacturer during preparation. |
| Administration: |
An in-line membrane filter may be used for administration.21 FOOTNOTE: Only the specified amphotericin B product requires the user to provide a filter.d Amphotericin B lipid complex (Abelcet) should be prepared using the filter needle provided by the manufacturer.179 |
|
andexanet alfa (Andexxa)Admin: 0.2-0.22 micron
| Filter size: |
0.2-0.22 micron |
| Administration: |
Administer with a PES or equivalent low-protein-binding in-line filter.22 |
|
| Andexxa - see andexanet alfa |
anifrolumab (Saphnelo)Admin: 0.2-15 micron
| Filter size: |
0.2-15 micron |
| Administration: |
Administer with a sterile, low-protein-binding, in-line or add-on filter.23 |
|
ansuvimab (Ebanga)Admin: 1.2 micron
| Filter size: |
1.2 micron |
| Administration: |
Administer with an in-line filter extension set.24 |
|
| Anthim - see obiltoxaximab |
antihemophilic factor VIII/Von Willebrand factor complex (Alphanate, Humate P, Wilate)Prep: 15 micron
| Filter size: |
15 micronb |
| Preparation: |
Use the filter vial transfer set provided by the manufacturer.25-27 The manufacturer of Humate P states that another double-ended needle and vented filter spike can be used for reconstitution in place of the filter vial transfer set.26 |
|
antithymocyte globulin (Thymoglobulin)Admin: 0.22 micron
| Filter size: |
0.22 micron |
| Administration: |
Administer with an in-line filter.28 |
|
| Aralast - see alpha-1 proteinase inhibitor |
| Atgam - see lymphocyte immune globulin, antithymocyte globulin |
atoltivimab, maftivimab, and odesivimab-ebgn (Inmazeb)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, in-line or add-on filter.29 |
|
| Aurlumyn - see iloprost |
avalglucosidase alfa (Nexviazyme)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with an in-line, low-protein-binding filter.30 |
|
avelumab (Bavencio)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter.31 |
|
| Avsola - see inFLIXimab-axxq |
axatilimab-csfr (Niktimvo)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, low-protein-binding in-line or add-on PES filter.32 |
|
| B |
generic (Brand)AdminPrep |
| BabyBIG - see botulism immune globulin IV |
| BAT - see botulism antitoxin heptavalent |
| Bavencio - see avelumab |
belatacept (Nulojix)Admin: 0.2-1.2 micron
| Filter size: |
0.2-1.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding filter.33 |
|
| Beleodaq - see belinostat |
belinostat (Beleodaq)Admin: 0.22 micron
| Filter size: |
0.22 micron |
| Administration: |
Administer with an in-line filter.34 |
|
| Berinert - see C1 esterase inhibitor (human) |
bezlotoxumab (Zinplava)Admin: 0.2-5 micron
| Filter size: |
0.2-5 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line or add-on filter.35 |
|
| Bizengri - see zenocutuzumab-zbco |
blinatumomab (Blincyto)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
24- or 48-hour infusion: Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter.36 7-day infusion: An in-line filter is not required.36 |
|
| Blincyto - see blinatumomab |
botulism antitoxin heptavalent (BAT)Admin: 15 micron
| Filter size: |
15 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter.37 |
|
botulism immune globulin IV (BabyBIG)Admin: 18 micron
| Filter size: |
18 micron |
| Administration: |
Administer with a sterile in-line or syringe-tip disposable filter.38 |
|
| Byooviz - see ranibizumaba |
| C |
generic (Brand)AdminPrep |
C1 esterase inhibitor (human) (Berinert, Cinryze, Haegarda)Prep: See comments
| Filter size: |
15 micronb (Berinert, Haegarda); 5 micronb (Cinryze) |
| Preparation: |
Use the filter vial transfer set provided by the manufacturer or another double-ended needle and vented filter spike during preparation.39-41 |
|
cabazitaxel (Jevtana)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with an in-line filter.42 |
|
casimersen (Amondys 45)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with an in-line filter.43 |
|
casirivimab and imdevimab (REGEN-COV)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, in-line or add-on PES filter.44 |
|
cemiplimab-rwlc (Libtayo)Admin: 0.2-5 micron
| Filter size: |
0.2-5 micron |
| Administration: |
Administer with a sterile, in-line or add-on, low-protein-binding filter.6,45 |
|
cetuximab (Erbitux)Admin: 0.22 micron
| Filter size: |
0.22 micron |
| Administration: |
Administer with a low-protein-binding in-line filter.46 |
|
| Cimerli - see ranibizumaba |
| Cinqair - see reslizumab |
| Cinryze - see C1 esterase inhibitor (human) |
cipaglucosidase alfa-atga (Pombiliti)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a low-protein-binding in-line filter. Change the filter if it becomes blocked.47 |
|
cladribine (Leustatin)Prep: 0.22 micron
| Filter size: |
0.22 micron |
| Preparation: |
Single daily dose injection: Use a sterile disposable hydrophilic syringe filter during preparation.48-50 7-day infusion: Use a sterile disposable hydrophilic syringe filter during preparation for both cladribine and diluent solutions as recommended by the manufacturer.48-50 |
|
| Clinimix - see amino acids |
| Clinisol - see amino acids |
| Clinolipid - see lipid emulsion |
clofarabine (Clolar)Prep: 0.2 micron
| Filter size: |
0.2 micron |
| Preparation: |
Use a sterile syringe filter during preparation prior to dilution.51 |
|
| Clolar - see clofarabine |
| Columvi - see glofitamab-gxbm |
| Cosela - see trilaciclib |
| Cosentyx - see secukinumab |
cosibelimab-ipdl (Unloxcyt)Admin: 0.2-0.22 micron
| Filter size: |
0.2-0.22 micron |
| Administration: |
Administer with a sterile, in-line or add-on filter.52 |
|
| Cresemba - see isavuconazonium sulfate |
crizanlizumab-tmca (Adakveo)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, in-line filter. No incompatibility has been observed with filter membranes composed of PES (neutral and positively charged), polyamide (positively charged), and polysulphone.53 |
|
crovalimab-akkz (Piasky)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with an in-line filter.54 |
|
| Cyramza - see ramucirumab |
cysteine (Elcys)Admin: 0.22 micron
| Filter size: |
0.22 micron |
| Administration: |
Administer with an in-line filter if given without lipid emulsion.55 |
|
| Cytogam - see cytomegalovirus immune globulin IV, (human) |
cytomegalovirus immune globulin IV, (human) (Cytogam)Admin: 15 or 0.2 micron
| Filter size: |
15 or 0.2 micron |
| Administration: |
Administer with an in-line filter.56 |
|
| D |
generic (Brand)AdminPrep |
daratumumab (Darzalex)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with an in-line, sterile, non-pyrogenic, low-protein-binding PES filter.57 |
|
| Darzalex - see daratumumab |
defibrotide (Defitelio)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with an in-line filter.58 |
|
| Defitelio - see defibrotide |
| Dilantin - see phenytoin sodium, parenteral |
dostarlimab (Jemperli)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line or add-on filter.59 |
|
durvalumab (Imfinzi)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with a sterile, low-protein-binding in-line filter.60 |
|
| E |
generic (Brand)AdminPrep |
| Ebanga - see ansuvimab |
efgartigimod alfa (Vyvgart)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with an in-line filter.61 |
|
| Elahere - see mirvetuximab soravtansine-gynx |
| Elaprase - see idursulfase |
| Elcys - see cysteine |
| Elelyso - see taliglucerase alfa |
| Elfabrio - see pegunigalsidase alfa-iwxj |
elosulfase alfa (Vimizim)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a low-protein-binding in-line filter.62 |
|
elotuzumab (Empliciti)Admin: 0.2-1.2 micron
| Filter size: |
0.2-1.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding filter.63 |
|
| Elzonris - see tagraxofusp-erzs |
emapalumab-lzsg (Gamifant)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter.64 |
|
emicizumab (Hemlibra)Prep: 5 micron
| Filter size: |
5 micron |
| Preparation: |
Use a transfer needle with filter to withdraw from the vial. The needle should be sterile, stainless steel, with a Luer lock, 18 gauge x 1.5 inch, single bevel or semi-blunted tip, single-use, latex-free, and non-pyrogenic.65 |
|
| Empliciti - see elotuzumab |
| Enhertu - see fam-trastuzumab deruxtecan-nxki |
| Enjaymo - see sutimlimab-jome |
epoprostenol sodium (Flolan, Veletri)Admin: 0.22 micron
| Filter size: |
0.22 micron |
| Administration: |
Administer with an in-line filter.66,67 |
|
eptinezumab-jjmr (Vyepti)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with a sterile, in-line or add-on filter.68 |
|
| Erbitux - see cetuximab |
eteplirsen (Exondys 51)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with an in-line filter.69 |
|
evinacumab-dgnb (Evkeeza)Admin: 0.2-5 micron
| Filter size: |
0.2-5 micron |
| Administration: |
Administer with a sterile, in-line or add-on filter.70 |
|
| Evkeeza - see evinacumab-dgnb |
| Exondys 51 - see eteplirsen |
| F |
generic (Brand)AdminPrep |
| Fabrazyme - see agalsidase beta |
fam-trastuzumab deruxtecan-nxki (Enhertu)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with an in-line, PES or polysulfone filter.71 |
|
| Flolan - see epoprostenol sodium |
fosdenopterin hydrobromide (Nulibry)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a filter.72 |
|
| Fungizone - see amphotericin B deoxycholate |
| G |
generic (Brand)AdminPrep |
gallium dotatate GA-68 (Netspot)Prep: 0.2 micron
| Filter size: |
0.2 micron |
| Preparation: |
Use a sterile self-venting filter during preparation according to the generator system-specific reconstitution instructions provided in the package insert.73 |
|
gallium GA-68 gozetotide (Illuccix, Locametz)Prep: 0.2 micron
| Filter size: |
0.2 micron |
| Preparation: |
Use a sterile self-venting filter during preparation according to the generator system-specific reconstitution instructions provided in the package insert.74,75 |
|
galsulfase (Naglazyme)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a low-protein-binding in-line filter, do not use a filter during preparation.76 |
|
| Gamifant - see emapalumab-lzsg |
| Gammagard S/D - see immune globulin IV |
gemtuzumab ozogamicin (Mylotarg)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with an in-line PES filter.77 |
|
| Glassia - see alpha-1 proteinase inhibitor |
glofitamab-gxbm (Columvi)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, in-line filter. No incompatibility has been observed with filters made of PES or polysulfone.78 |
|
golimumab (Simponi aria)Admin: 0.22 micron or smaller
| Filter size: |
0.22 micron or smaller |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter.79 FOOTNOTE: A prefilled syringe formulation is also available under a different brand name (Simponi).e |
|
golodirsen (Vyondys 53)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with an in-line filter.80 |
|
| H |
generic (Brand)AdminPrep |
| Haegarda - see C1 esterase inhibitor (human) |
hemin (Panhematin)Admin: 0.45 micron or smaller
| Filter size: |
0.45 micron or smaller |
| Administration: |
Administer with an in-line filter.5,7,81 |
|
| Hemlibra - see emicizumab |
human plasma proteins (Octaplas)Admin: See comments
| Filter size: |
See comments |
| Administration: |
Administer with an in-line filter.82 The manufacturer does not provide a filter size recommendation,but following standard blood product filtering procedures can be considered since this is a plasma-based product.8,82 |
|
| Humate P - see antihemophilic factor VIII/Von Willebrand factor complex |
| I |
generic (Brand)AdminPrep |
ibritumomab tiuxetan (Zevalin)Admin: 0.22 micron
| Filter size: |
0.22 micron |
| Administration: |
Administer with a low-protein-binding in-line filter.83 |
|
idursulfase (Elaprase)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a low-protein-binding in-line filter.84 |
|
| Illuccix - see gallium GA-68 gozetotide |
iloprost (Aurlumyn)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with an in-line filter.85 |
|
| Imfinzi - see durvalumab |
| Imjudo - see tremelimumab |
immune globulin IV (Gammagard S/D)Admin: 15 micron
| Filter size: |
15 micron |
| Administration: |
Administer Gammagard S/D with the infusion set provided by the manufacturer or another filter-containing administration set.86 All other products do not require filtration. FOOTNOTE: All brand names have been checked, but only the specified brand name product(s) require filtration. The most up-to-date package insert should be periodically reviewed for the most current recommendations.a |
|
| Imuldosa - see ustekinumab-srlf |
inebilizumab (Uplizna)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with a sterile, low-protein-binding, in-line filter.87 |
|
| Inflectra - see inFLIXimab-dyyb |
inFLIXimab (Remicade)Admin: 1.2 micron or smaller
| Filter size: |
1.2 micron or smaller |
| Administration: |
Administer with a sterile non-pyrogenic, low-protein-binding in-line filter.88-91 |
|
inFLIXimab-abda (Renflexis)Admin: 1.2 micron or smaller
| Filter size: |
1.2 micron or smaller |
| Administration: |
Administer with a sterile non-pyrogenic, low-protein-binding in-line filter.88-91 |
|
inFLIXimab-axxq (Avsola)Admin: 1.2 micron or smaller
| Filter size: |
1.2 micron or smaller |
| Administration: |
Administer with a sterile non-pyrogenic, low-protein-binding in-line filter.88-91 |
|
inFLIXimab-dyyb (Inflectra)Admin: 1.2 micron or smaller
| Filter size: |
1.2 micron or smaller |
| Administration: |
Administer with a sterile non-pyrogenic, low-protein-binding in-line filter.88-91 |
|
| Inmazeb - see atoltivimab, maftivimab, and odesivimab-ebgn |
| Intralipid - see lipid emulsion |
ipilimumab (Yervoy)Admin: 0.2 or 1.2 micron
| Filter size: |
0.2 or 1.2 micronb |
| Administration: |
Administer with a sterile non-pyrogenic, low-protein-binding in-line filter.92 Ipilimumab is compatible with 0.2 and 1.2 micron PES filters and 0.2 micron nylon filters.b |
|
isatuximab (Sarclisa)Admin: 0.22 micron
| Filter size: |
0.22 micron |
| Administration: |
Administer with an in-line filter (PES, polysulfone, or nylon).93 |
|
isavuconazonium sulfate (Cresemba)Admin: 0.2-1.2 micron
| Filter size: |
0.2-1.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic in-line filter.5,94 |
|
ixabepilone (Ixempra kit)Admin: 0.2-1.2 micron
| Filter size: |
0.2-1.2 micron |
| Administration: |
Administer with an in-line filter.95 |
|
| Ixempra kit - see ixabepilone |
| J |
generic (Brand)AdminPrep |
| Jemperli - see dostarlimab |
| Jevtana - see cabazitaxel |
| K |
generic (Brand)AdminPrep |
| Kabiven - see amino acids, electrolytes, dextrose, and lipid injectable |
| Kadcyla - see ado-trastuzumab emtansine |
| Kanuma - see sebelipase alfa |
| Keytruda - see pembrolizumab |
| Kimmtrak - see tebentafusp-tebn |
| L |
generic (Brand)AdminPrep |
| Lamzede - see velmanase alfa-tycv |
laronidase (Aldurazyme)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a low-protein-binding in-line filter; do not use a filter during preparation.96 |
|
lecanemab-irmb (Leqembi)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a low-protein-binding in-line filter.97 |
|
| Leqembi - see lecanemab-irmb |
letermovir (Prevymis)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with an in-line PES filter.98 |
|
| Leustatin - see cladribine |
| Libtayo - see cemiplimab-rwlc |
lipid emulsion (Clinolipid, Intralipid, Nutrilipid, Omegaven, Smoflipid)Admin: 1.2 micron
| Filter size: |
1.2 micron |
| Administration: |
An in-line filter should be used when administering lipid emulsion, both alone and as part of an admixture.8,9,99-104 |
| IMH Comment: |
1.2 micron filter required, will be sent from pharmacy with each bag (along with a fat emulsion IV set). |
|
| Locametz - see gallium GA-68 gozetotide |
loncastuximab tesirine (Zynlonta)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding, in-line or add-on filter.105 |
|
| Loqtorzi - see toripalimab-tpzi |
| Lumizyme - see alglucosidase alfa |
| Lutathera - see lutetium Lu 177 dotatate |
lutetium Lu 177 dotatate (Lutathera)Prep: Not available
| Filter size: |
Not available |
| Preparation: |
Use a filtered 20 gauge x 2.5 cm needle during preparation.106 |
|
lymphocyte immune globulin, antithymocyte globulin (Atgam)Admin: 0.2-1 micron
| Filter size: |
0.2-1 micron |
| Administration: |
Administer with an in-line filter.107 |
|
| M |
generic (Brand)AdminPrep |
mannitolAdmin: 0.2 micron
| Filter size: |
See comments |
| Administration: |
Administer with an in-line filter when infusing concentrated mannitol (20% or more) due to the potential for crystal formation; some resources state to administer with an in-line filter for concentrations of 15% or more.5,7 No current manufacturer provides a filter size recommendation.108-111 One source currently suggests a filter size between 0.2 and 5 microns.7 |
| IMH Comment: |
Use a 0.2 micron filter |
|
| Margenza - see margetuximab-cmkb |
margetuximab-cmkb (Margenza)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding, PES in-line or add-on filter.112 |
|
| Mepsevii - see vestronidase alfa-vjbk |
methacholine (Provocholine)Prep: 0.22 micron
| Filter size: |
0.22 micron |
| Preparation: |
Use a sterile, bacterial-retentive filter during preparation when transferring solution from each vial (at least 2 mL) to a nebulizer.113 |
|
mirvetuximab soravtansine-gynx (Elahere)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with an in-line PES filter.114 |
|
mogamulizumab-kpkc (Poteligeo)Admin: 0.22 micron
| Filter size: |
0.22 micron |
| Administration: |
Administer with a sterile, low-protein-binding in-line filter.115 |
|
| Mylotarg - see gemtuzumab ozogamicin |
| N |
generic (Brand)AdminPrep |
| Naglazyme - see galsulfase |
| Netspot - see gallium dotatate GA-68 |
| Nexterone - see amiodarone |
| Nexviazyme - see avalglucosidase alfa |
| Niktimvo - see axatilimab-csfr |
nivolumab (Opdivo)Admin: 0.2-1.2 micron
| Filter size: |
0.2-1.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter.116 |
|
nivolumab and relatlimab-rmbw (Opdualag)Admin: 0.2-1.2 micron
| Filter size: |
0.2-1.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter made of PES, nylon, or PVDF.117 |
|
| Noxafil - see posaconazole |
| Nulibry - see fosdenopterin hydrobromide |
| Nulojix - see belatacept |
| Nutrilipid - see lipid emulsion |
| O |
generic (Brand)AdminPrep |
obiltoxaximab (Anthim)Admin: 0.22 micron
| Filter size: |
0.22 micron |
| Administration: |
Administer with an in-line filter.118 |
|
ocrelizumab (Ocrevus)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with an in-line filter.119 |
|
| Ocrevus - see ocrelizumab |
| Octaplas - see human plasma proteins |
olipudase alfa (Xenpozyme)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a low-protein-binding in-line filter made of PES or polytetrafluoroethylene.120 |
|
| Omegaven - see lipid emulsion |
| Onpattro - see patisiran |
| Opdivo - see nivolumab |
| Opdualag - see nivolumab and relatlimab-rmbw |
| Orencia - see abatacept |
| Otulfi - see ustekinumab-aauz |
| P |
generic (Brand)AdminPrep |
PACLitaxel (Taxol)Admin: 0.22 micron or smaller
| Filter size: |
0.22 micron or smaller |
| Administration: |
Administer conventional PACLitaxel with an in-line filter. |
|
PACLitaxel, protein-bound (Abraxane)Admin: N/A
| Filter size: |
N/A |
| Administration: |
A filter is not needed for the albumin-bound formulation (Abraxane).121,122 FOOTNOTE: The currently marketed brand name product (Abraxane) does not require filtration.f |
|
| Panhematin - see hemin |
panitumumab (Vectibix)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with a low-protein-binding in-line filter.123 |
|
patisiran (Onpattro)Admin: 1.2 micronPrep: 0.45 micron
| Filter size: |
0.45 micron (preparation), 1.2 micron (administration) |
| Preparation: |
Use a sterile PES syringe filter during preparation. |
| Administration: |
Administer with a PES in-line filter.124 |
|
pegunigalsidase alfa-iwxj (Elfabrio)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, low-protein-binding in-line filter.7,125 |
|
pembrolizumab (Keytruda)Admin: 0.2-5 micron
| Filter size: |
0.2-5 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line or add-on filter.126 |
|
| Pemgarda - see pemivibart |
pemivibart (Pemgarda)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with an in-line filter.127 |
|
| Perikabiven - see amino acids, electrolytes, dextrose, and lipid injectable |
phenytoin sodium, parenteral (Dilantin)Admin: 0.22 micron
| Filter size: |
0.22-0.55 micron |
| Administration: |
If giving as an intermittent infusion, administer with an in-line filter.128 |
| IMH Comment: |
For IV infusions, use a 0.22 micron in-line filter. |
|
| Piasky - see crovalimab-akkz |
| Plenamine - see amino acids |
polatuzumab vedotin-piiq (Polivy)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding, in-line or add-on filter.129 |
|
| Polivy - see polatuzumab vedotin-piiq |
| Pombiliti - see cipaglucosidase alfa-atga |
posaconazole (Noxafil)Admin: 0.22 micron
| Filter size: |
0.22 micron |
| Administration: |
Administer with a PES or PVDF in-line filter.6,130 |
|
| Poteligeo - see mogamulizumab-kpkc |
pozelimab-bbfg (Veopoz)Admin: 0.2-5 micron
| Filter size: |
0.2-5 micron |
| Administration: |
Administer with a sterile, in-line or add-on filter.131 |
|
| Premasol - see amino acids |
| Prevymis - see letermovir |
| Prolastin C Liquid - see alpha-1 proteinase inhibitor |
| ProSol - see amino acids |
| Provocholine - see methacholine |
| Pyzchiva - see ustekinumab-ttwe |
| R |
generic (Brand)AdminPrep |
ramucirumab (Cyramza)Admin: 0.22 micron
| Filter size: |
0.22 micron |
| Administration: |
Administer with a protein-sparing filter.132 |
|
ranibizumaba (Byooviz, Cimerli, Susvimo)Admin: 5 micronPrep: 5 micron
| Filter size: |
5 micron |
| Preparation: |
Use a 19 gauge x 1.5 inch sterile filter needle during preparation. |
| Administration: |
Use a non-filter needle for the intravitreal injection.133-135 |
|
ravulizumab-cwvz (Ultomiris)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with a low-protein-binding in-line filter.136 |
|
| REGEN-COV - see casirivimab and imdevimab |
| Remicade - see inFLIXimab |
| Remodulin - see treprostinil |
| Renflexis - see inFLIXimab-abda |
reslizumab (Cinqair)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a low-protein-binding in-line filter; Cinqair is compatible with PES, PVDF, nylon, and cellulose acetate in-line filters.137 |
|
retifanlimab-dlwr (Zynyz)Admin: See comments
| Filter size: |
See comments |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding PES, PVDF, or cellulose acetate in-line or add-on 0.2 to 5 micron filter. A 15 micron mesh in-line or add-on filter can also be used.138 |
|
| Rybrevant - see amivantamab |
| S |
generic (Brand)AdminPrep |
| Saphnelo - see anifrolumab |
| Sarclisa - see isatuximab |
sebelipase alfa (Kanuma)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a low-protein-binding in-line filter.139 |
|
secukinumab (Cosentyx)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter.140 |
|
siltuximab (Sylvant)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with an in-line PES filter.141 |
|
| Simponi aria - see golimumab |
| Smoflipid - see lipid emulsion |
spesolimab-sbzo (Spevigo)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter. No incompatibility has been observed with filters composed of PES (neutral and positively charged) and polyamide (positively charged).142 |
|
| Spevigo - see spesolimab-sbzo |
| Stelara - see ustekinumaba |
| Steqeyma - see ustekinumab-stba |
| Susvimo - see ranibizumaba |
sutimlimab-jome (Enjaymo)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with an in-line PES filter.143 |
|
| Sylvant - see siltuximab |
| Synthamin - see amino acids |
| T |
generic (Brand)AdminPrep |
tagraxofusp-erzs (Elzonris)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a PES in-line filter; manufacturer recommends attaching the filter while preparing (priming) the infusion set.144 |
|
taliglucerase alfa (Elelyso)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a low-protein-binding in-line filter.145 |
|
| Taxol - see PACLitaxel |
tebentafusp-tebn (Kimmtrak)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter.146 |
|
temsirolimus (Torisel)Admin: See comments
| Filter size: |
5 micron or smaller (in-line filter), 0.2-5 micron (end-set filter) |
| Administration: |
Administer with an in-line PES filter or an end-set PES filter if an in-line filter is not available. Do not use both an in-line and an end-set filter.147 |
|
| Tepadina - see thiotepa |
| Tepylute - see thiotepa |
| Tevimbra - see tislelizumab-jsgr |
thiotepa (Tepadina, Tepylute)Admin: See comments
| Filter size: |
0.2147-151 or 0.22 micron 152,153 |
| Administration: |
Administer with an in-line filter148-154; some generic manufacturers recommend filtering with a polysulfone membrane or triton-free mixed ester of cellulose/PVC filter prior to administration; solutions of generic thiotepa (10-300 µg/mL) did not adsorb to cellulose nitrite, cellulose acetate ester, or Teflon filters.6,7,153,154 FOOTNOTE: Both the specified branded product and the conventional generic product require filtration.c |
|
| Thymoglobulin - see antithymocyte globulin |
tislelizumab-jsgr (Tevimbra)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line or add-on filter.155 |
|
tisotumab vedotin (Tivdak)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with an in-line filter.156 |
|
| Tivdak - see tisotumab vedotin |
toripalimab-tpzi (Loqtorzi)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with an aseptic in-line filter.157 |
|
| Torisel - see temsirolimus |
| TPN - see amino acids |
trabectedin (Yondelis)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a PES in-line filter.158 |
|
| Travasol - see amino acids |
tremelimumab (Imjudo)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with a sterile, low-protein-binding in-line filter.159 |
|
treprostinil (Remodulin)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with an in-line filter.160-163 |
|
trilaciclib (Cosela)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with an in-line filter made of PES, PVDF, or cellulose acetate.164 |
|
| TrophAmine - see amino acids |
| U |
generic (Brand)AdminPrep |
| Ultomiris - see ravulizumab-cwvz |
| Unloxcyt - see cosibelimab-ipdl |
| Uplizna - see inebilizumab |
ustekinumab (Stelara)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter.165-170 FOOTNOTE: All brand names have been checked, but only the specified brand name product(s) require filtration. The most up-to-date package insert should be periodically reviewed for the most current recommendations.a |
|
ustekinumab-aauz (Otulfi)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter.165-170 |
|
ustekinumab-auub (Wezlana)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter.165-170 |
|
ustekinumab-srlf (Imuldosa)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter.165-170 |
|
ustekinumab-stba (Steqeyma)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter.165-170 |
|
ustekinumab-ttwe (Pyzchiva)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding in-line filter.165-170 |
|
| V |
generic (Brand)AdminPrep |
| Vectibix - see panitumumab |
velaglucerase alfa (Vpriv)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with a low-protein-binding in-line filter.171 |
|
| Veletri - see epoprostenol sodium |
velmanase alfa-tycv (Lamzede)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a low-protein-binding in-line filter.172 |
|
| Veopoz - see pozelimab-bbfg |
verteporfin (Visudyne)Admin: 1.2 micron
| Filter size: |
1.2 micron |
| Administration: |
Administer with an in-line filter.173 |
|
vestronidase alfa-vjbk (Mepsevii)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a low-protein-binding in-line filter.174 |
|
| Vimizim - see elosulfase alfa |
| Visudyne - see verteporfin |
| Vpriv - see velaglucerase alfa |
| Vyepti - see eptinezumab-jjmr |
| Vyloy - see zolbetuximab-clzb |
| Vyondys 53 - see golodirsen |
| Vyvgart - see efgartigimod alfa |
| W |
generic (Brand)AdminPrep |
| Wezlana - see ustekinumab-auub |
| Wilate - see antihemophilic factor VIII/Von Willebrand factor complex |
| X |
generic (Brand)AdminPrep |
| Xenpozyme - see olipudase alfa |
| Y |
generic (Brand)AdminPrep |
| Yervoy - see ipilimumab |
| Yondelis - see trabectedin |
| Z |
generic (Brand)AdminPrep |
| Zaltrap - see ziv-aflibercept |
zanidatamab-hrii (Ziihera)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron |
| Administration: |
Administer with a filter. The infusion solution is compatible with PES or PVDF filters.175 |
|
| Zemaira - see alpha-1 proteinase inhibitor |
zenocutuzumab-zbco (Bizengri)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
Administer with a sterile, non-pyrogenic, low-protein-binding PES in-line filter.176 |
|
| Zevalin - see ibritumomab tiuxetan |
| Ziihera - see zanidatamab-hrii |
| Zinplava - see bezlotoxumab |
ziv-aflibercept (Zaltrap)Admin: 0.2 or 0.22 micron
| Filter size: |
0.2 or 0.22 micron 6,174 |
| Administration: |
Administer with a PES filter. Do not use filters made of PVDF or nylon.177 |
|
zolbetuximab-clzb (Vyloy)Admin: 0.2 micron
| Filter size: |
0.2 micron |
| Administration: |
An in-line filter is recommended. The infusion solution is compatible with PES or polysulfone filters.178 |
|
| Zynlonta - see loncastuximab tesirine |
| Zynyz - see retifanlimab-dlwr |
| |
generic (Brand)AdminPrep |
| Footnotes |
| Note. ASPEN = American Society of Parenteral and Enteral Nutrition; INS = Infusion Nurses Society; IV = intravenous; PES = polyethersulfone; PN = parenteral nutrition; PVDF = polyvinylidene fluoride. |
| a All brand names have been checked, but only the specified brand name product(s) require filtration. The most up-to-date package insert should be periodically reviewed for the most current recommendations. |
| b Filter size not specified in product labeling; size information was obtained via personal communication with manufacturer. |
| c Both the specified branded product and the conventional generic product require filtration. |
| d Only the specified amphotericin B product requires the user to provide a filter. Amphotericin B lipid complex (Abelcet) should be prepared using the filter needle provided by the manufacturer.179 An in-line filter (1 micron or larger) may be used during administration of amphotericin B desoxycholate.180-182 |
| e A prefilled syringe formulation is also available under a different brand name. |
| f The currently marketed brand name product does not require filtration. |